Clinical trials recruiting for Schizoaffective Disorder

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• 40 Hz Visual Stimulation as an Intervention in Schizophrenia
  NCT06907420 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
  NCT07105111 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 22 locations
• Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Disorders
  NCT07395206 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Anticholinergic Deprescription in Schizophrenia
  NCT06562608 · Phase: Phase 4 · Ages: 40 Years to 70 Years · Sex: All (male and female) · 1 location
• Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
  NCT06740383 · Phase: Not specified · Ages: 18 Years to 40 Years · Sex: All (male and female) · 6 locations
• Brain Health and Exercise in Schizophrenia
  NCT01392885 · Phase: Not specified · Ages: 19 Years to 45 Years · Sex: All (male and female) · 1 location
• CLOZAPINE Response in Biotype-1
  NCT04580134 · Phase: Phase 4 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 5 locations
• Cerebellar Modulation of Cognition in Psychosis
  NCT06107764 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
  NCT05208190 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 7 locations
• Cognitive Strategies in Early Psychosis 2
  NCT07263022 · Phase: Phase 3 · Ages: 18 Years to 35 Years · Sex: All (male and female) · 1 location
• Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)
  NCT06865937 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Database Registry for Neural Network Biomarkers in Psychosis
  NCT01409109 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study
  NCT06745479 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: All (male and female) · 1 location
• Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination
  NCT04629352 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Effectiveness of Motivation Skills Training (MST)
  NCT05805397 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Enhanced Coordinated Specialty Care for Early Psychosis
  NCT06071858 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 5 locations
• Enhancing Rehabilitation for Veterans With Serious Mental Illness
  NCT06586164 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 83 Years · Sex: All (male and female) · 1 location
• Enhancing Veteran-Clinical Collaboration in VA PRRCs
  NCT06898879 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Exercise and Olanzapine-samidorphan
  NCT06740890 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
  NCT05890183 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Integrative Neuro-social Cognitive Strategy Programme for Instilling REcovery (INSPIRE) a Community-Based Cognitive Remediation Trial
  NCT06286202 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 60 Years · Sex: All (male and female) · 5 locations
• Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder
  NCT06221852 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
• Magnetic Seizure Therapy for Schizophrenia - Trial
  NCT06672588 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• MicroRNAs as Biomarkers in First Episode Schizophrenia
  NCT07703670 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 40 Years · Sex: All (male and female) · 1 location
• Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents
  NCT06904079 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
  NCT07098169 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 3 locations
• Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
  NCT03495024 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
  NCT02639702 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Synbiotic Compound to Reduce Symptoms of Schizophrenia
  NCT04226898 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia.
  NCT07058389 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care
  NCT06005766 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Schizoaffective Disorder often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Schizoaffective Disorder trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.